Latest AI and machine learning research in other cancers for healthcare professionals.
The tumor immune microenvironment (TME) is pivotal in regulating cancer initiation, progression, and therapeutic response. Despite major advances in immunotherapy, clinical outcomes remain limited by low response rates and unpredictable immune-related adverse events (irAEs). Surface-enhanced Raman scattering (SERS) technology, with its single-molecule sensitivity and multiplexing capabilities, off...
Nanozymes are enzyme-mimicking nanomaterials that are promising for diverse biomedical applications; they enable stable, tunable, and multifunctional cancer therapies via exploiting tumor microenvironment (TME) cues to regulate reactive oxygen species (ROS) and catalytic activities locally, aided by state-of-the-art fabrication methods and artificial intelligence (AI)-assisted designs. This review...
BACKGROUND: Hepatocellular carcinoma (HCC) is a common and aggressive form of cancer. There is an interplay between ferroptosis and lipid metabolism i...
PURPOSE: Upper tract urothelial carcinoma (UTUC) is a rare but aggressive malignancy where accurate preoperative assessment of tumour grade and stage ...
OBJECTIVE: To predict cartilage tumor malignancy from radiographic images combined with readily available non-imaging information based on a vision-la...
BACKGROUND: Breast cancer is a leading cause of cancer-related mortality worldwide, with poor prognosis largely due to its invasive and metastatic nat...
Although the risk of progression varies, a subset of patients with idiopathic cytopenia of undetermined significance (ICUS) eventually develop myeloid...
UNLABELLED: T-cell leukemias and lymphomas (TCL) form a heterogeneous group of rare and often aggressive malignancies. Because of the rarity and heter...
INTRODUCTION: Sarcomas are rare, molecularly diverse malignancies that challenge accurate diagnosis and effective therapy. Japan has implemented natio...
BACKGROUND: Cutaneous melanoma is one of the most aggressive forms of skin cancer, marked by rapid progression, early metastasis, and high resistance ...
BACKGROUND: Renal cell carcinoma (RCC) is a common, often lethal kidney cancer that originates in the renal cortex. Its incidence is rising, and major...
Transcriptomic assays such as the PAM50-based ROR-P score guide recurrence risk stratification in non-metastatic, ER-positive, HER2-negative breast ca...
INTRODUCTION: Interventional oncology (IO) is a key component of multidisciplinary cancer care, delivering minimally invasive therapies with safety an...
BACKGROUND: Wild-type transthyretin amyloidosis (ATTRwt) is a serious condition. At early stages, symptoms resemble those of heart failure with preser...
RATIONALE AND OBJECTIVES: PD-L1 expression is a critical biomarker in guiding immunotherapy for gastric cancer (GC). This study aims to investigate th...
PURPOSE: Accurate preoperative assessment of regional lymphatic metastases (LNM) is essential for effective surgical selection of patients with colore...
OBJECTIVE: Image quality evaluation in radiology is most relevant when reflects radiologists' performance. This study assessed how image quality measu...
Pleural diseases pose a significant burden on healthcare systems due to diagnostic challenges and high costs. Artificial intelligence (AI) has the pot...
PURPOSE: Local tumor progression (LTP) of hepatocellular carcinoma (HCC) after thermal ablation (TA) is related to tumor invasiveness and threaten the...
BACKGROUND: Advances in next-generation sequencing(NGS) and multi-omics approaches reinforced the concept of functional diversity within biofilm commu...